Aillis develops and provides digital solutions focused on enhancing the quality of life for the elderly and supporting healthcare professionals. The company specializes in creating platforms that facilitate remote monitoring and personalized care management for aging populations. Their technology aims to improve efficiency in long-term care settings while ensuring better health outcomes for users.
Funding
$41.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PTFounders
Product
Problem
Current methods for influenza detection often lack the speed and accuracy needed for timely intervention, hindering effective treatment and contributing to the virus's spread. Traditional diagnostic processes can be slow, and less accurate methods may lead to misdiagnosis and inappropriate treatment decisions.
Solution
Aillis is developing an AI-powered medical device designed to improve the speed and accuracy of influenza detection. The device uses advanced diagnostic algorithms to analyze patient data and identify influenza infections more effectively than traditional methods. By providing rapid and reliable results, Aillis aims to enable prompt treatment initiation, reduce the transmission of the virus, and improve patient outcomes. The company's technology seeks to create a more open and collaborative approach to healthcare.
Target Audience
The primary target audience includes healthcare providers, hospitals, and diagnostic laboratories seeking to improve the speed and accuracy of influenza detection.
Features
- AI-powered diagnostic algorithms for enhanced influenza detection
- Rapid analysis of patient data for timely results
- Intended to improve the accuracy of influenza diagnosis compared to traditional methods